BRCA2 and breast cancer: The germline mutation rate of the members of the Fanconi anemia gene family (including BRCA2, PALB2, and RAD51C) was 25.93% (7/27) among patients with germline mutations in TNBC, which was lower than those in unselected breast cancer (35).